These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 7556724)

  • 1. Immunological non-responsiveness and acquisition of tolerance in relation to immune privilege in the eye.
    Streilein JW
    Eye (Lond); 1995; 9 ( Pt 2)():236-40. PubMed ID: 7556724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune privilege in the anterior chamber of the eye.
    Niederkorn JY
    Crit Rev Immunol; 2002; 22(1):13-46. PubMed ID: 12186187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the induction of anterior chamber-associated immune deviation (ACAID). III. Induction of ACAID depends upon intraocular transforming growth factor-beta.
    Wilbanks GA; Mammolenti M; Streilein JW
    Eur J Immunol; 1992 Jan; 22(1):165-73. PubMed ID: 1530916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the induction of anterior chamber-associated immune deviation (ACAID). 1. Evidence that an antigen-specific, ACAID-inducing, cell-associated signal exists in the peripheral blood.
    Wilbanks GA; Streilein JW
    J Immunol; 1991 Apr; 146(8):2610-7. PubMed ID: 1707912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that peritoneal exudate cells cultured with eye-derived fluids are the proximate antigen-presenting cells in immune deviation of the ocular type.
    Hara Y; Okamoto S; Rouse B; Streilein JW
    J Immunol; 1993 Nov; 151(10):5162-71. PubMed ID: 8228216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune privilege, T-cell tolerance, and tissue-restricted autoimmunity.
    Streilein JW; Takeuchi M; Taylor AW
    Hum Immunol; 1997 Feb; 52(2):138-43. PubMed ID: 9077562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-1 receptor antagonist therapy and induction of anterior chamber-associated immune deviation-type tolerance after corneal transplantation.
    Yamada J; Zhu SN; Streilein JW; Dana MR
    Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4203-8. PubMed ID: 11095616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of splenic B cells in the immune privilege of the anterior chamber of the eye.
    Niederkorn JY; Mayhew E
    Eur J Immunol; 1995 Oct; 25(10):2783-7. PubMed ID: 7589072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local production of IFN-gamma abrogates the intraocular immune privilege in transgenic mice and prevents the induction of ACAID.
    Geiger K; Sarvetnick N
    J Immunol; 1994 Dec; 153(11):5239-46. PubMed ID: 7525729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluids from immune privileged sites endow macrophages with the capacity to induce antigen-specific immune deviation via a mechanism involving transforming growth factor-beta.
    Wilbanks GA; Streilein JW
    Eur J Immunol; 1992 Apr; 22(4):1031-6. PubMed ID: 1551403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gamma delta T cells are needed for ocular immune privilege and corneal graft survival.
    Skelsey ME; Mellon J; Niederkorn JY
    J Immunol; 2001 Apr; 166(7):4327-33. PubMed ID: 11254685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the induction of anterior chamber-associated immune deviation (ACAID). II. Eye-derived cells participate in generating blood-borne signals that induce ACAID.
    Wilbanks GA; Mammolenti M; Streilein JW
    J Immunol; 1991 May; 146(9):3018-24. PubMed ID: 2016537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of anterior chamber-associated immune deviation with suppression of corneal epithelial rejection in mice.
    Yao YF; Inoue Y; Miyazaki D; Hara Y; Shimomura Y; Tano Y; Ohashi Y
    Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):292-300. PubMed ID: 9040461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of ocular immune responses.
    Streilein JW
    Eye (Lond); 1997; 11 ( Pt 2)():171-5. PubMed ID: 9349408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fate of orthotopic corneal allografts in eyes that cannot support anterior chamber-associated immune deviation induction.
    Sano Y; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 1995 Oct; 36(11):2176-85. PubMed ID: 7558710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood-borne signals that induce anterior chamber-associated immune deviation after intracameral injection of antigen.
    Streilein JW; Okamoto S; Hara Y; Kosiewicz M; Ksander B
    Invest Ophthalmol Vis Sci; 1997 Oct; 38(11):2245-54. PubMed ID: 9344347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD8+ T regulatory cells use a novel genetic program that includes CD103 to suppress Th1 immunity in eye-derived tolerance.
    Keino H; Masli S; Sasaki S; Streilein JW; Stein-Streilein J
    Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1533-42. PubMed ID: 16565389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of anterior chamber-associated immune deviation by corneal allografts placed in the anterior chamber.
    Yamada J; Streilein JW
    Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2833-43. PubMed ID: 9418737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphoma allografts abrogate immune privilege within the anterior chamber of the eye.
    Niederkorn JY; Streilein JW
    Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1235-43. PubMed ID: 3089965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of cyclosporine on anterior chamber-associated immune deviation with retinal transplantation.
    Ishioka M; Okamoto S; Streilein JW; Jiang LQ
    Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):2152-60. PubMed ID: 9331279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.